“The science we bring forward is at the heart of this symposium.” Two days remain to submit late-breaking abstracts to #SABCS26. Program Director Kate Lathrop, MD, discusses how researchers can still contribute to the global scientific conversation in SABCS Meeting News: https://bit.ly/4xIVBEA
San Antonio Breast Cancer Symposium
@sabcs.bsky.social
SABCS is the world's largest gathering of doctors, researchers and scientists sharing state-of-the-art information on experimental biology, etiology, prevention, diagnosis, and therapy for breast cancer and premalignant breast diseases. www.sabcs.org
Register by September 25 to get the lowest rates for #SABCS26 and join the breast cancer community in San Antonio December 8-11. Learn more: buff.ly/3pDrDf2
When should endocrine therapy change for patients with HR-positive metastatic breast cancer? Drs. Virginia Kaklamani, Erika Hamilton and Komal Jhaveri discuss SERENA-4, SERENA-6 and imlunestrant + abemaciclib in this SABCS Snippet. #SABCS26. Watch: https://youtu.be/-wsO5LQXJgE
SABCS Snippets - SERENA-4, SERENA-6 and the timing of endocrine therapy - September 18, 2026
YouTube video by San Antonio Breast Cancer Symposium
youtu.be
Make your hotel reservations by November 30 to ensure the lowest available rates for #SABCS26. Learn more: buff.ly/miRnSAs
104 countries. More than 11,000 attendees. One global breast cancer community driving progress in research and care. #SABCS26 returns to San Antonio December 8–11. Tell us where you’re coming from in the comments.
In this SABCS® Snippet, Kate I. Lathrop, MD, William Gradishar, MD, and Seth Wander, MD join patient advocate Julia Maués to discuss camizestrant’s accelerated FDA approval and what the findings could mean for patients and clinical practice. #SABCS https://www.youtube.com/watch?v=BKf0AMbyo3I
SABCS Snippets – FDA Approval of Camizestrant – September 4, 2026
YouTube video by San Antonio Breast Cancer Symposium
youtube.com
Register by September 25 to get the lowest rates for #SABCS26 (December 8-11). Learn more: buff.ly/3pDrDf2
Camizestrant received accelerated FDA approval Friday. At #SABCS25, François-Clément Bidard, MD, presented updated Phase 3 SERENA-6 results showing how ctDNA can detect treatment resistance before disease progression. What will we see next? Join us at #SABCS26, Dec. 8–11. https://bit.ly/463weSl
The SABCS community mourns the loss of Sandi Stanford, a pioneer in patient advocacy, a fierce leader, mentor and friend to so many. Her impact on the breast cancer community is immeasurable. She will be deeply missed. Share your photos and memories of Sandi in the comments.
Secure the best available hotels for #SABCS26 (December 8-11); make your reservations now. Learn more: buff.ly/miRnSAs
More than 2,300 abstracts have been submitted for #SABCS26. But there’s still time to contribute to the program. Researchers with important new findings can submit a late-breaking abstract through Sept. 30: bit.ly/3Up5JVa What will everyone be talking about this year?
Join the global breast cancer community Dec. 8–11 in San Antonio for four days of new science, emerging therapies, and cutting-edge research spanning the full spectrum of breast cancer prevention, diagnosis, treatment, and survivorship. Register now. https://bit.ly/463weSl
The #SABCS26 program is now available. From AI-based pathology and prevention vaccines to ctDNA and radioligand therapies, see what’s ahead in breast cancer research and make plans to join us Dec. 8-11. https://bit.ly/4ggQ7LM
“In the next decade, we really expect to be able to cure patients with breast cancer.” Every December, the global breast cancer community comes to San Antonio to share the latest discoveries and advance breast cancer research and care. Join us at #SABCS26, Dec. 8–11.
The #SABCS26 Early Registration deadline is September 25. Register now and be a part of the world's premier breast cancer meeting, December 8-11. Learn more: buff.ly/3pDrDf2
Individual Housing Deadline: November 30— Make your hotel reservations for #SABCS26 now and join us in San Antonio December 8-11. Learn more: buff.ly/miRnSAs
Register by September 25 to get the lowest rates for #SABCS26 and join the breast cancer community in San Antonio December 8-11. Learn more: buff.ly/3pDrDf2
Housing is open for #SABCS26 (December 8-11). Make your reservations now to secure the best available hotels. Deadline: November 30. Learn more: buff.ly/miRnSAs
Registration is now open for #SABCS26. Register by September 25 to get the lowest rates and join the breast cancer community in San Antonio December 8-11. Learn more: buff.ly/3pDrDf2
Abstract submission for #SABCS26 closes at 11:59 PM Central U.S. time today, Monday, July 13. Submit an abstract today and make plans to join us in San Antonio December 8-11. Learn more: buff.ly/TJKb4se
The abstract deadline for #SABCS26 is July 13. Submit an abstract today and join us December 8-11 for the most important breast cancer meeting in the world. Learn more: buff.ly/TJKb4se
Breast cancer clinicians and scientists from around the world will come together at #SABCS26 (December 8-11). Submit an abstract by July 13 and join them. Learn more: buff.ly/TJKb4se
Submit an abstract by July 13 and share your work with the global breast cancer research community at #SABCS26 (December 8-11). Learn more: buff.ly/TJKb4se
The abstract deadline for #SABCS26 is July 13. Submit an abstract today and join us December 8-11 for the most important breast cancer meeting in the world. Learn more: buff.ly/TJKb4se
SABCS co-directors Virginia Kaklamani, MD, and Carlos Arteaga, MD, and program director Kate Lathrop, MD, joined colleagues from around the world at #ASCO26 last week. What discoveries will define the next chapter of breast cancer research? Join us at #SABCS26 to find out. @vkaklamani.bsky.social
Breast cancer clinicians and scientists from around the world will come together at #SABCS26 (December 8-11). Submit an abstract by July 13 and join them. Learn more: buff.ly/TJKb4se
The William L. McGuire Award and Lectureship—which honors Dr. McGuire, a co-founder of SABCS—will be presented at #SABCS26 to recognize an investigator who has made enduring contributions to breast cancer research and patient care. Nominate a colleague by May 29: buff.ly/9iRLmv0